Regulation	0	10	O
of	11	13	O
thrombospondin	14	28	B-Gene_or_gene_product
-	28	29	I-Gene_or_gene_product
1	29	30	I-Gene_or_gene_product
by	31	33	O
natural	34	41	O
and	42	45	O
synthetic	46	55	O
progestins	56	66	B-Drug_or_compound
in	67	69	O
human	70	75	B-Organism
breast	76	82	B-Cell
cancer	83	89	I-Cell
cells	90	95	I-Cell
.	95	96	O

Our	98	101	O
recent	102	108	O
studies	109	116	O
show	117	121	O
that	122	126	O
progestins	127	137	B-Drug_or_compound
induce	138	144	O
vascular	145	153	B-Gene_or_gene_product
endothelial	154	165	I-Gene_or_gene_product
growth	166	172	I-Gene_or_gene_product
factor	173	179	I-Gene_or_gene_product
(	180	181	O
VEGF	181	185	B-Gene_or_gene_product
)	185	186	O
in	187	189	O
breast	190	196	B-Cell
cancer	197	203	I-Cell
cells	204	209	I-Cell
that	210	214	O
express	215	222	O
mutant	223	229	O
p53	230	233	B-Gene_or_gene_product
protein	234	241	O
.	241	242	O

Here	243	247	O
,	247	248	O
we	249	251	O
show	252	256	O
that	257	261	O
natural	262	269	O
and	270	273	O
synthetic	274	283	O
progestins	284	294	B-Drug_or_compound
also	295	299	O
induce	300	306	O
thrombospondin	307	321	B-Gene_or_gene_product
-	321	322	I-Gene_or_gene_product
1	322	323	I-Gene_or_gene_product
(	324	325	O
TSP	325	328	B-Gene_or_gene_product
-	328	329	I-Gene_or_gene_product
1	329	330	I-Gene_or_gene_product
)	330	331	O
mRNA	332	336	O
and	337	340	O
protein	341	348	O
in	349	351	O
T47	352	355	B-Cell
-	355	356	I-Cell
D	356	357	I-Cell
and	358	361	O
BT	362	364	B-Cell
-	364	365	I-Cell
474	365	368	I-Cell
breast	369	375	I-Cell
cancer	376	382	I-Cell
cells	383	388	I-Cell
.	388	389	O

Antiprogestin	390	403	B-Drug_or_compound
RU	404	406	I-Drug_or_compound
-	406	407	I-Drug_or_compound
486	407	410	I-Drug_or_compound
inhibits	411	419	O
the	420	423	O
induction	424	433	O
of	434	436	O
VEGF	437	441	B-Gene_or_gene_product
and	442	445	O
TSP	446	449	B-Gene_or_gene_product
-	449	450	I-Gene_or_gene_product
1	450	451	I-Gene_or_gene_product
by	452	454	O
progestins	455	465	B-Drug_or_compound
,	465	466	O
suggesting	467	477	O
that	478	482	O
this	483	487	O
effect	488	494	O
of	495	497	O
progestin	498	507	B-Drug_or_compound
is	508	510	O
mediated	511	519	O
by	520	522	O
the	523	526	O
progesterone	527	539	B-Gene_or_gene_product
receptor	540	548	I-Gene_or_gene_product
(	549	550	O
PR	550	552	B-Gene_or_gene_product
)	552	553	O
.	553	554	O

Actinomycin	555	566	B-Drug_or_compound
-	566	567	I-Drug_or_compound
D	567	568	I-Drug_or_compound
,	568	569	O
but	570	573	O
not	574	577	O
puromycin	578	587	B-Drug_or_compound
,	587	588	O
also	589	593	O
blocks	594	600	O
progestin	601	610	B-Drug_or_compound
-	610	611	O
dependent	611	620	O
induction	621	630	O
of	631	633	O
TSP	634	637	B-Gene_or_gene_product
-	637	638	I-Gene_or_gene_product
1	638	639	I-Gene_or_gene_product
.	639	640	O

A	641	642	O
putative	643	651	O
progestin	652	661	B-Drug_or_compound
-	661	662	O
response	662	670	O
element	671	678	O
was	679	682	O
identified	683	693	O
in	694	696	O
the	697	700	O
human	701	706	B-Organism
TSP	707	710	B-Gene_or_gene_product
-	710	711	I-Gene_or_gene_product
1	711	712	I-Gene_or_gene_product
promoter	713	721	O
,	721	722	O
which	723	728	O
is	729	731	O
consistent	732	742	O
with	743	747	O
the	748	751	O
hypothesis	752	762	O
that	763	767	O
a	768	769	O
progestin	770	779	B-Drug_or_compound
-	779	780	O
PR	780	782	B-Gene_or_gene_product
complex	783	790	O
might	791	796	O
directly	797	805	O
regulate	806	814	O
transcription	815	828	O
of	829	831	O
the	832	835	O
TSP	836	839	B-Gene_or_gene_product
-	839	840	I-Gene_or_gene_product
1	840	841	I-Gene_or_gene_product
gene	842	846	O
in	847	849	O
human	850	855	B-Organism
cells	856	861	B-Cell
.	861	862	O

Conditioned	863	874	O
medium	875	881	O
from	882	886	O
progestin	887	896	B-Drug_or_compound
-	896	897	O
treated	897	904	O
breast	905	911	B-Cell
cancer	912	918	I-Cell
cells	919	924	I-Cell
stimulates	925	935	O
endothelial	936	947	B-Cell
cell	948	952	I-Cell
proliferation	953	966	O
in	967	969	O
the	970	973	O
absence	974	981	O
though	982	988	O
not	989	992	O
in	993	995	O
the	996	999	O
presence	1000	1008	O
of	1009	1011	O
antibody	1012	1020	O
to	1021	1023	O
TSP	1024	1027	B-Gene_or_gene_product
-	1027	1028	I-Gene_or_gene_product
1	1028	1029	I-Gene_or_gene_product
,	1029	1030	O
indicating	1031	1041	O
that	1042	1046	O
TSP	1047	1050	B-Gene_or_gene_product
-	1050	1051	I-Gene_or_gene_product
1	1051	1052	I-Gene_or_gene_product
secreted	1053	1061	O
by	1062	1064	O
breast	1065	1071	B-Cell
cancer	1072	1078	I-Cell
cells	1079	1084	I-Cell
could	1085	1090	O
be	1091	1093	O
pro	1094	1097	O
-	1097	1098	O
angiogenic	1098	1108	O
.	1108	1109	O

Since	1110	1115	O
tumor	1116	1121	B-Cell
cell	1122	1126	I-Cell
-	1126	1127	O
derived	1127	1134	O
TSP	1135	1138	B-Gene_or_gene_product
-	1138	1139	I-Gene_or_gene_product
1	1139	1140	I-Gene_or_gene_product
has	1141	1144	O
the	1145	1148	O
potential	1149	1158	O
to	1159	1161	O
promote	1162	1169	O
angiogenesis	1170	1182	O
in	1183	1185	O
the	1186	1189	O
tumor	1190	1195	B-Pathological_formation
microenvironment	1196	1212	O
,	1212	1213	O
it	1214	1216	O
could	1217	1222	O
be	1223	1225	O
a	1226	1227	O
potential	1228	1237	O
target	1238	1244	O
for	1245	1248	O
breast	1249	1255	B-Pathological_formation
cancer	1256	1262	I-Pathological_formation
therapy	1263	1270	O
.	1270	1271	O

